5-HT4R expression has been found to be reduced in AD patients, while the activation of these receptors inhibits the (e.g., AC-cAMP-PKA) biochemical cascades that lead to AD (Fig. 1) (Hagena and Manahan-Vaughan, 2017; Reynolds et al., 1995). The gene discussed is HTR4; the disease is Alzheimer disease.